Marlena Broncel

3.2k total citations · 1 hit paper
118 papers, 2.0k citations indexed

About

Marlena Broncel is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marlena Broncel has authored 118 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 27 papers in Cardiology and Cardiovascular Medicine and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marlena Broncel's work include Lipoproteins and Cardiovascular Health (23 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers) and Cancer, Lipids, and Metabolism (14 papers). Marlena Broncel is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers) and Cancer, Lipids, and Metabolism (14 papers). Marlena Broncel collaborates with scholars based in Poland, United States and Finland. Marlena Broncel's co-authors include Maria Koter−Michalak, Paulina Gorzelak‐Pabiś, Joanna Sikora, Piotr Duchnowicz, Ewelina Woźniak, Maciej Chałubiński, J Chojnowska-Jezierska, Marzena Koziróg, Adam Rafał Poliwczak and Elżbieta Mikiciuk‐Olasik and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Marlena Broncel

109 papers receiving 1.9k citations

Hit Papers

Neuroprotective Effect of SGLT2 Inhibitors 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neuroprotective Effect of SGLT2 Inhibitors
    2021 181 citations Marlena Broncel, Ewelina Woźniak et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlena Broncel Poland 25 465 455 438 302 299 118 2.0k
Zhuo Fu China 29 866 1.9× 646 1.4× 1.1k 2.6× 196 0.6× 593 2.0× 59 2.8k
Beata Kieć‐Wilk Poland 27 557 1.2× 309 0.7× 748 1.7× 215 0.7× 766 2.6× 123 2.3k
Antonio García‐Ríos Spain 29 405 0.9× 295 0.6× 492 1.1× 147 0.5× 875 2.9× 81 2.3k
Maria Assunta Potenza Italy 24 311 0.7× 216 0.5× 708 1.6× 251 0.8× 701 2.3× 61 2.4k
Roberto Miatello Argentina 23 456 1.0× 134 0.3× 391 0.9× 237 0.8× 407 1.4× 55 1.6k
Thomas Wallerath Germany 17 418 0.9× 272 0.6× 651 1.5× 319 1.1× 1.0k 3.4× 20 2.5k
Cristina M. Sena Portugal 28 559 1.2× 350 0.8× 879 2.0× 172 0.6× 865 2.9× 72 2.9k
Saad Abdulrahman Hussain Iraq 23 364 0.8× 182 0.4× 340 0.8× 118 0.4× 221 0.7× 126 2.1k
Emiliano Duranti Italy 28 298 0.6× 273 0.6× 288 0.7× 85 0.3× 519 1.7× 52 1.8k
Milan Obradović Serbia 23 441 0.9× 324 0.7× 590 1.3× 64 0.2× 590 2.0× 78 2.4k

Countries citing papers authored by Marlena Broncel

Since Specialization
Citations

This map shows the geographic impact of Marlena Broncel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlena Broncel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlena Broncel more than expected).

Fields of papers citing papers by Marlena Broncel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlena Broncel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlena Broncel. The network helps show where Marlena Broncel may publish in the future.

Co-authorship network of co-authors of Marlena Broncel

This figure shows the co-authorship network connecting the top 25 collaborators of Marlena Broncel. A scholar is included among the top collaborators of Marlena Broncel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlena Broncel. Marlena Broncel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bukowska, Bożena, et al.. (2025). Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case Reports of Adverse Drug Interactions in Humans. International Journal of Molecular Sciences. 26(11). 5188–5188. 3 indexed citations
2.
Gorzelak‐Pabiś, Paulina, et al.. (2024). OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy. Journal of Cellular and Molecular Medicine. 28(14). e18459–e18459. 4 indexed citations
3.
Broncel, Marlena, et al.. (2023). Mitral valve prolapse—arrhythmic faces of the valve disease. SHILAP Revista de lepidopterología. 1(2). 72–87.
4.
Broncel, Marlena, et al.. (2023). SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol. Molecules. 28(3). 1112–1112. 5 indexed citations
5.
Woźniak, Ewelina, et al.. (2023). The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells. PLoS ONE. 18(2). e0280741–e0280741. 17 indexed citations
6.
Gonciarz, Weronika, Agnieszka Krupa, Tomasz Rechciński, et al.. (2022). Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease. Journal of Clinical Medicine. 11(9). 2545–2545. 6 indexed citations
7.
Banach, Maciej, Jarosław Kaźmierczak, Przemysław Mitkowski, et al.. (2022). Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.. Archives of Medical Science. 18(3). 569–576. 12 indexed citations
8.
9.
Gorzelak‐Pabiś, Paulina, et al.. (2021). Rivaroxaban protects from the oxysterol-induced damage and inflammatory activation of the vascular endothelium. Tissue Barriers. 9(4). 1956284–1956284. 11 indexed citations
10.
Broncel, Marlena, et al.. (2021). Neuroprotective Effect of SGLT2 Inhibitors. Molecules. 26(23). 7213–7213. 181 indexed citations breakdown →
11.
12.
Gorzelak‐Pabiś, Paulina, et al.. (2021). COVID-19: Direct and Indirect Mechanisms of Statins. International Journal of Molecular Sciences. 22(8). 4177–4177. 33 indexed citations
13.
Woźniak, Ewelina, Marlena Broncel, Bożena Bukowska, & Paulina Gorzelak‐Pabiś. (2020). The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol. International Journal of Molecular Sciences. 21(6). 1953–1953. 24 indexed citations
14.
Koter−Michalak, Maria, et al.. (2016). The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study. Advances in Clinical and Experimental Medicine. 25(3). 433–439. 2 indexed citations
15.
Broncel, Marlena, Kamila Wójcik, & Elżbieta Jabłonowska. (2015). Expanding role of single tablets regimens in selected therapeutic areas. 1 indexed citations
16.
Sikora, Joanna, et al.. (2009). The effect of atorvastatin on the erythrocyte plasma membrane and C-reactive protein in menopausal women with metabolic syndrome. 8(4). 233–238. 2 indexed citations
17.
Broncel, Marlena. (2007). [Antiatherosclerotic properties of flavones from the roots of Scutellaria baicalensis Georgi].. PubMed. 60(5-6). 294–7. 11 indexed citations
18.
Broncel, Marlena, et al.. (2007). Physicochemical modifications induced by statins therapy on human erythrocytes membranes.. PubMed. 60(7-8). 321–8. 11 indexed citations
19.
Broncel, Marlena, et al.. (2007). [Melatonin in the treatment of atherosclerosis].. PubMed. 23(134). 124–7. 9 indexed citations
20.
Broncel, Marlena, et al.. (2002). The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. European Journal of Clinical Pharmacology. 58(8). 501–506. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuo Fu Breakdown of academic impact, for papers by Beata Kieć‐Wilk Breakdown of academic impact, for papers by Antonio García‐Ríos Breakdown of academic impact, for papers by Maria Assunta Potenza Breakdown of academic impact, for papers by Roberto Miatello Breakdown of academic impact, for papers by Thomas Wallerath Breakdown of academic impact, for papers by Cristina M. Sena Breakdown of academic impact, for papers by Saad Abdulrahman Hussain Breakdown of academic impact, for papers by Emiliano Duranti Breakdown of academic impact, for papers by Milan Obradović
Rankless by CCL
2026